Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Samcro Hyosung Adilestari Tbk. (ACRO) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Samcro Hyosung Adilestari Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Samcro Hyosung Adilestari Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Samcro Hyosung Adilestari Tbk. trades at Rp63 (market cap 218.57B, 5.19M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Samcro Hyosung Adilestari Tbk. is the larger of the two by market cap, and Samcro Hyosung Adilestari Tbk. is more actively traded (5.19M versus 187.4K). Which is the better fit depends on your goals.

ACROOBAT
Market Cap
218.57B164.65B
Volume
5.19M187.4K
Lot
51.94K1.87K
Turnover
327.46M44.35M
Average Price
63.04236.67
Value
327.46M44.35M
Indicative Equilibrium Price
63242
Indicative Equilibrium Volume
957500

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ACRO
View details
OBAT
View details

About Samcro Hyosung Adilestari Tbk.

PT Samcro Hyosung Adilestari Tbk (The Company) was established on Republic of Indonesia based on Deed of Establishment No. 265 dated July 21, 1989 by Yudo Paripurno, S.H., Notary in Jakarta.

Read more on ACRO

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT